SAN FRANCISCO, July 31 /PRNewswire/ --

- Featured Case Study: Hawaii's Successful Produce Safety RFID Pilot

TechInsights announced the final agenda for the "Food Traceability: Securing the Food Supply Chain" workshop to be held during the RFID World 2008 conference in Las Vegas at the MGM Grand, September 8-10 (http://www.rfid-world.com/2008). The workshop addresses recent food safety crises and includes a presentation of the results of an extensive produce traceability case study funded by the Economic Development Alliance of Hawaii and administered by the Hawaii Farm Bureau Federation.

LONDON, July 31 /PRNewswire/ --

- Traffic Speed Forecasting Enables HGVs to Avoid Time-Based Congestion Patterns to Reduce Fuel Consumption

Journey Dynamics, a privately-owned provider of traffic intelligence (http://www.journeydynamics.com), today announces the availability of traffic speed data for Heavy Good Vehicles (HGVs) to forecast accurate speeds across the entire UK road infrastructure. This information, based on high quality floating vehicle data supplied by ITIS Holdings plc, will enable a new generation of HGV speed forecasting applications that are able to predict arrival times, improve journey confidence and minimise the fuel costs by avoiding time-based traffic congestion patterns.

NUREMBERG, Germany, July 31 /PRNewswire/ -- NCP engineering GmbH, a leading provider of endpoint security and VPN solutions, today announced the release of its Secure Entry Client for Symbian OS-based mobile devices. The new IPSec VPN client can be used on mobile devices such as the Nokia Eseries, which run Symbian OS from V.9.0 on S60 3rd Edition.

BASINGSTOKE, England and PHILADELPHIA, July 31 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to June 30, 2008.

Q2 2008 Financial Highlights - Product sales up 40% to $706m - Product sales excluding ADDERALL XR(R) up 64% to $409m - New product sales(1) $243m, 34% of product sales (2007: 18%) - Total revenues up 35% to $776m - US GAAP earnings per ADS: loss $0.44 (2007: loss $9.93) - Non GAAP earnings per ADS up 70% to $0.95 (2007: $0.56) - Revenue guidance upgraded - 2008 revenue growth now expected to be at least 20% (previous guidance: mid to high teens) (1) New product sales comprise DAYTRANA, ELAPRASE, FOSRENOL, LIALDA / MEZAVANT and VYVANSE

LONDON, July 31 /PRNewswire/ -- YouTube has been criticised by MPs, who say it must do more to vet its content - http://news.bbc.co.uk/1/hi/technology/7533543.stm.

Martin Warner (http://www.Martinwarner.com) is a new media expert and will be available today for analysis and comment relating to this story. In particular Martin can discuss:

- The consequences

- What it actually means for YouTube and similar websites

- What it means for uploaders

- What is likely to happen following this announcement

Press enquiries to Vicky Lyons and Kully Dhadda +44(0)207-233-7578 mb +44(0)7884246858, kully@flamepr.co.uk

BASEL, Switzerland, July 31 /PRNewswire/ --

- Submission Based on Phase III Study Showing Superior Results for MabThera in Chronic Lymphocytic Leukaemia (CLL) When Added to Standard Chemotherapy

Today, Roche submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for the use of its biotechnology drug MabThera (rituximab) as first-line treatment of chronic lymphocytic leukaemia, the most common form of adult leukaemia.